Work

Colonic inflammation and cancer are driven by elevated D‐2‐hydroxyglutarate levels in an EglN1‐dependent mechanism

Year: 2017

Type: article

Source: The FASEB Journal

DOI: 10.1096/fasebj.31.1_supplement.1046.1

Authors: Arianne L. Theiss, Jie Han, Kevin O. Turner, Robert M. Genta, Lawrence Sweetman

Institutions: Baylor Scott & White Research Institute, The University of Texas Southwestern Medical Center

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Cancer Prevention and Research Institute of Texas

Award: Elevated D-2-hydroxyglutarate precedes and promotes tumor progression in inflammatory bowel diseases

OpenAlex ID: W4389006961

FWCI:

Cites:

Cited by:

Related to: 10